Anja Pedersen

530 total citations
8 papers, 317 citations indexed

About

Anja Pedersen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Anja Pedersen has authored 8 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Anja Pedersen's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anja Pedersen is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anja Pedersen collaborates with scholars based in Denmark, Norway and Sweden. Anja Pedersen's co-authors include Peter de Nully Brown, Kirsten Grønbæk, Simon Husby, Carsten Utoft Niemann, Christian H. Geisler, Maj Westman, Per Guldberg, Mats Jerkeman, Arne Kolstad and Christina Dahl and has published in prestigious journals such as Blood, Oncotarget and Bioorganic & Medicinal Chemistry.

In The Last Decade

Anja Pedersen

8 papers receiving 313 citations

Peers

Anja Pedersen
Kathryn Turner United Kingdom
Brian Munneke United States
Grit Hutter Germany
James Watkins United Kingdom
Jiří Mayer Czechia
Fary Diop Italy
Jefferson Parker United States
Jae Werndli United States
Kathryn Turner United Kingdom
Anja Pedersen
Citations per year, relative to Anja Pedersen Anja Pedersen (= 1×) peers Kathryn Turner

Countries citing papers authored by Anja Pedersen

Since Specialization
Citations

This map shows the geographic impact of Anja Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Pedersen more than expected).

Fields of papers citing papers by Anja Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Pedersen. The network helps show where Anja Pedersen may publish in the future.

Co-authorship network of co-authors of Anja Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Pedersen. A scholar is included among the top collaborators of Anja Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Pedersen. Anja Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Eskelund, Christian Winther, Christina Dahl, Jakob Werner Hansen, et al.. (2017). TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 130(17). 1903–1910. 242 indexed citations
2.
Asmar, Fazila, Konstantinos Dimopoulos, Peter de Nully Brown, et al.. (2016). TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy. Acta Neuropathologica Communications. 4(1). 40–40. 16 indexed citations
3.
Asmar, Fazila, Christoffer Hother, Marianne Bach Treppendahl, et al.. (2014). Diffuse large B-cell lymphoma with combinedTP53mutation andMIR34Amethylation: Another “double hit” lymphoma with very poor outcome?. Oncotarget. 5(7). 1912–1925. 22 indexed citations
4.
Asmar, Fazila, Christoffer Hother, Marianne Bach Treppendahl, et al.. (2013). Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?. Blood. 122(21). 83–83. 2 indexed citations
5.
Hother, Christoffer, Fazila Asmar, Marianne Bach Treppendahl, et al.. (2012). miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A, and MIR34B/C. Blood. 120(21). 296–296. 2 indexed citations
6.
Asmar, Fazila, Jens Peter Christensen, Jens Vilstrup Johansen, et al.. (2011). TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes. Blood. 118(21). 1364–1364. 1 indexed citations
7.
Peschke, Bernd, Magali Zundel, Trine Ryberg Clausen, et al.. (2007). C-Terminally PEGylated hGH-derivatives. Bioorganic & Medicinal Chemistry. 15(13). 4382–4395. 22 indexed citations
8.
Płytycz, Barbara, Anja Pedersen, Jarl Bøgwald, & Rolf Seljelid. (1986). In vitro interactions of murine peritoneal macrophages and sarcoma cells. Virchows Archiv B Cell Pathology Including Molecular Pathology. 50(1). 285–292. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026